Pharma IQ Members

17 results
of 2
Tony Hitchcock

A More Balanced Understanding Of “Risk”

Earlier this year I was fortunate enough to attend the Disposable Solutions meeting in Munich. A common theme of discussions was the on-going debates around the issues of leachable and extractables and the associated testing standards. This is a topic that has been debated for as long as I have been attending meetings on single use systems, and still seems to be a long way from a consensus between various end users and manufacturing bodies on how to address this issue.

by: Tony Hitchcock
Published: May 10, 2016
Tags:


Tony Hitchcock

The Translation of Next Generation Therapeutics

When we look at the current trends with what we can refer to as “next generation therapeutics”, whether it be ADCs or cell and gene therapy products, one trend is very clear, products are becoming increasingly complex in their nature. Certainly, the complexity of the manufacturing processes used to produce them clearly reflects this; hand in hand with ever increasing product development costs and timelines.

by: Tony Hitchcock
Published: March 22, 2016
Tags: manufacturing, pharmaceuticals, pharma, biotechnologies, biotech, biopharma, therapeutics, gene therapy, cell therapies,, disposable manufacturing, vaccinces,, CMOs, pharma firms, Big Pharma, SME pharma, drug developer, Tony Hitchcock, contract development


Knowledge Exchange

The phrase Knowledge Exchange (KE) describing collaborations between industry and the academic community is recognised as having been a key factor in the development of the bio-pharmaceutical sector over recent year

by:
Published: December 21, 2015
Tags: knowledge exchange, partnership, academic groups, pharma, biotech, market access, mergers and acquisitions,


Tony Hitchcock

Fit for Purpose

At Cobra we have worked on the development of both naked plasmid DNA and viral gene therapy products for over 20 years. After some rather extended development times, it has been very rewarding to see a number progress out of Phase II clinical studies and customers wanting to take these products into Phase III studies.

by: Tony Hitchcock
Published: September 22, 2015
Tags: manufacturing, technologies, Tony Hitchcock, processes, DNA, gene therapy, genomics, clinical evaluation, clinical experience


Tony Hitchcock

The Rocky Road to Success

Having worked in the development and production of early stage therapeutics for over 30 years I appreciate as much as anyone that this is often a highly challenging environment, not least with regards to overcoming technical and regulatory hurdles as well as seeking to meet a highly demanding timeline.

by: Tony Hitchcock
Published: June 3, 2015
Tags: research and development, theraputics, therapeutics, CMO, Colin Love, Amgen, Bio-Vex, clinical evaluation, T-Vec


Tony Hitchcock

Disposables Solutions 2015

With this year’s Disposables Solutions meeting in Munich rapidly approaching I will focus this blog on some of the issues which I hope will be covered in presentations and discussions.

by: Tony Hitchcock
Published: February 9, 2015
Tags: disposables solutions, Tony Hitchcock, single-use systems, single- use, biomanufacturing


Tony Hitchcock

If Single Use is now the Norm

With single use systems becoming the norm, now is the time that industry must take stock of the situation and assess which are the challenges which may be hindering future progress. In this column Tony Hitchcock looks at these challenges and asks what can we in industry do to overcome them.

by: Tony Hitchcock
Published: September 18, 2014
Tags: Tony Hitchcock, disposable solutions, single use systems, pharma manufacturing


Tony Hitchcock

Where Next for Single Use Systems?

With the on-going maturation of single use systems, one of the growing discussions is on the topic of standardisation. With many companies and organisations being at cross purposes when it comes to these standards, it is up for debate whether standardisation will be possible. In this column, Tony Hitchcock dissects the issues surrounding this topic and asks whether this debate will ever be resolved.

by: Tony Hitchcock
Published: June 12, 2014
Tags: single use systems, disposable solutions, Standardisation, pharma manufacturing, Tony Hitchcock


Tony Hitchcock

What are the Real Drivers in the Disposables Market?

The way in which single-use systems are being used is changing. In this column Tony Hitchcock looks at what is driving these changes. He also looks to the future, analysing what trends might mean for the future of biomanufacturing.

by: Tony Hitchcock
Published: February 5, 2014
Tags: biomanufacturing, single-use systems, Tony Hitchcock, CMO, Biologics


Tony Hitchcock

Flexible Facilities- Single Use Systems

It is quite clear that flexible Facilities is currently a “hot” topic with a number of presentations and meetings being solely focused on this area. It has been clear for a number of years that single use systems have opened up a whole new area of possibilities with regards to facility requirements and operational models and that we are now seeing this concept turning into reality.

by: Tony Hitchcock
Published: December 9, 2013
Tags: flexible facilities, Tony Hitchcock, disposable solutions, single use systems


17 results
of 2